Scientific Publications Database

Article Title: Hematologic adverse events following palbociclib (PAL) dose reduction in patients (pts) with hormone receptor. positive (HR plus )/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Pooled analysis from randomized phas
Authors: Verma, Sunil; Im, Seock-Ah; Ro, Jungsil; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; Verma, Shailendra; Schnell, Patrick; Bananis, Eustratios; Lu, Dongrui (Ray); Ettl, Johannes; Cristofanilli, Massimo; Rugo, Hope S.; Finn, Richard S.
Journal: JOURNAL OF CLINICAL ONCOLOGY Volume 36 Issue 15
Date of Publication:2018
Abstract:
.